| Bioactivity | Cap-dependent endonuclease-IN-9 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-9 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo agent kinetic properties and in vivo pharmacodynamic properties. Cap-dependent endonuclease-IN-9 has strong inhibitory effect on RNA polymerase activity of A virus (extracted from patent CN112521386A, compound VI-1)[1]. |
| Name | Cap-dependent endonuclease-IN-9 |
| Formula | C29H26F2N4O7S |
| Molar Mass | 612.60 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yutian Zhou, et al. Polycyclic pyridone compounds with antiviral effects and their pharmaceutical compositions and uses. Patent CN112521386A. |
Cap-dependent endonuclease-IN-9
CAS: F: C29H26F2N4O7S W: 612.60
Cap-dependent endonuclease-IN-9 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent en
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.